Antibodies on nanoparticle surfaces may foster or fluster therapies

For nanomedicine to achieve the envisioned breakthroughs in disease treatment, scientists must learn why the immune system often responds inhospitably to these therapies. An NIH-funded team at the University of Colorado (UC) has assembled a clearer picture of the molecular activity that occurs when nanoparticles injected into the body are marked for immune system attack.

from Newswise Feature Channel: Women's Health https://ift.tt/2NvImCL